MYOKARDIA INC's ticker is MYOK and the CUSIP is 62857M105. A total of 157 filers reported holding MYOKARDIA INC in Q2 2019. The put-call ratio across all filers is 2.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $167,004,000 | +97.5% | 1,225,000 | +40.0% | 1.16% | +70.6% |
| Q2 2020 | $84,543,000 | +319.4% | 875,000 | +103.5% | 0.68% | +291.3% |
| Q1 2020 | $20,158,000 | -86.5% | 430,000 | -79.0% | 0.17% | -82.8% |
| Q4 2019 | $149,414,000 | +41.1% | 2,050,000 | +1.0% | 1.01% | +26.0% |
| Q3 2019 | $105,885,000 | +5.6% | 2,030,397 | +1.5% | 0.80% | +22.7% |
| Q2 2019 | $100,280,000 | -1.1% | 2,000,000 | +2.5% | 0.65% | -14.5% |
| Q1 2019 | $101,395,000 | +29.7% | 1,950,278 | +21.9% | 0.76% | +33.2% |
| Q4 2018 | $78,190,000 | -21.7% | 1,600,278 | +4.5% | 0.57% | -2.9% |
| Q3 2018 | $99,839,000 | +35.8% | 1,531,278 | +3.4% | 0.59% | +30.0% |
| Q2 2018 | $73,545,000 | +45.0% | 1,481,278 | +42.5% | 0.45% | +29.3% |
| Q1 2018 | $50,717,000 | +39.5% | 1,039,278 | +20.3% | 0.35% | +19.0% |
| Q4 2017 | $36,363,000 | +113.5% | 863,732 | +117.3% | 0.30% | +95.4% |
| Q3 2017 | $17,033,000 | – | 397,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 511,244 | $33,333,000 | 10.93% |
| Casdin Capital, LLC | 805,000 | $52,486,000 | 6.38% |
| Foresite Capital Management III, LLC | 372,300 | $24,274,000 | 5.36% |
| Fernwood Investment Management, LLC | 153,131 | $9,984,000 | 5.28% |
| Grace Capital | 121,304 | $7,909,000 | 3.10% |
| Cormorant Asset Management, LP | 700,000 | $45,640,000 | 2.97% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 917,000 | $59,788,000 | 2.14% |
| Perceptive Advisors | 1,089,169 | $71,014,000 | 1.90% |
| PFM Health Sciences, LP | 1,878,909 | $122,505,000 | 1.80% |
| Hillhouse Capital Management | 858,340 | $55,964,000 | 1.50% |